Single-Base Resolution Method of 5-hmC in Biology
生物学中5-hmC的单碱基解析方法
基本信息
- 批准号:8252069
- 负责人:
- 金额:$ 21.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAgingAntibodiesBiologicalBiological MarkersBiological ProcessBiological SciencesBiologyBiotinCellsChemicalsCommunitiesCytosineDNADetectionDevelopmentDigestionDiseaseDisease MarkerEpigenetic ProcessExodeoxyribonuclease IIIExonucleaseFutureGene ExpressionGenomeGenomic ImprintingGenomicsGlucoseGlucosyltransferaseHumanHypoxiaInvestigationLabelLaboratory ResearchLigationLocationMaintenanceMalignant NeoplasmsMammalian CellMedicineMethodsModificationMusNeurodegenerative DisordersPhasePlayPositioning AttributePrimer ExtensionReactionReagentRegulationResearchResearch PersonnelResolutionRoleSmall Business Innovation Research GrantTechnologyTestingTissuesWorkX Inactivationangiogenesisbasecancer cellembryonic stem cellfunctional groupglycosylationhuman diseaseleukemiamammalian genomenew technologynext generationsodium bisulfitestemsuccesstoolzygote
项目摘要
DESCRIPTION (provided by applicant): 5-Hydroxymethylcytosine (5-hmC) is a newly identified base modification in mammalian genomic DNA. Because current sequencing methods cannot differentiate 5-meC from 5-hmC, the immediate challenge is to develop robust methods to ascertain the positions of 5-hmC within the mammalian genome, a problem best addressed by adapting a new chemical labeling technology that we have developed. We show that the hydroxymethyl group of 5-hmC can be selectively labeled with chemically modified glucoses using 2-glucosyltransferase (2GT). This glycosylation offers a strategy of installing functional groups such as biotin onto 5-hmC. In this way, we can affinity capture DNA fragments containing the modified 5-hmC and develop sequencing methods to determine the precise locations of 5-hmC. Building on our early successes we propose to develop single base-resolution detection and sequencing methods to reveal the distribution of 5-hmC in mammalian genomes. We propose two different approaches, both utilizing the selective chemical labeling strategy we have developed. In one approach, we will label 5-hmC with bulky groups to hinder ligation and linear PCR reactions, thus achieving single base-resolution detection of 5-hmC. The linear PCR approach can be adapted into the next generation Solexa sequencing to perform high throughput determination of 5-hmC in mammalian genomes. In an alternative approach, we wil develop an exonuclease digestion blockage method that detects modified 5-hmC at 3' end of undigested DNA fragments using the next generation Solexa sequencing; we have already shown that the chemically modified 5-hmC blocks exonuclease III digestion at 3' end of the modified 5-hmC. The new technologies proposed in this SBIR application not only have great values as commercial research reagents, but also promise to efficiently discover and detect 5-hmC as biomarkers in various human diseases. !
PUBLIC HEALTH RELEVANCE: 5-Hydroxymethylcytosine (5-hmC) is a newly discovered base modification surprisingly abundant in the genomic DNAs of certain mammalian tissues and cells. The proposed work will develop efficient chemical labeling methods to perform single base-resolution detection and sequencing of 5-hmC in genomic DNAs. The success of the proposed work will enable the researchers to reveal the fundamental role(s) of 5-hmC in biology and develop potential disease markers.
描述(由申请人提供):5-羟基甲基胞嘧啶(5-HMC)是哺乳动物基因组DNA的新鉴定的基础修饰。由于当前的测序方法无法将5-MEC与5-HMC区分开,因此直接挑战是开发可靠的方法,以确定哺乳动物基因组中5-HMC的位置,这是通过调整我们开发的新化学标记技术来解决这个问题的问题。我们表明,使用2-葡萄糖基转移酶(2GT),可以将5-HMC的羟基基团选择性地标记。该糖基化提供了将生物素等功能组安装到5-HMC上的策略。通过这种方式,我们可以亲和力捕获包含修改的5-HMC的DNA片段并开发测序方法以确定5-HMC的精确位置。在我们的早期成功的基础上,我们建议开发单个基础分辨率检测和测序方法,以揭示5-HMC在哺乳动物基因组中的分布。我们提出了两种不同的方法,均利用我们制定的选择性化学标记策略。在一种方法中,我们将用笨重的基团标记5-HMC,以阻止连接和线性PCR反应,从而实现5-HMC的单基分辨率检测。线性PCR方法可以改编为下一代Solexa测序,以执行哺乳动物基因组中5-HMC的高吞吐测定。在另一种方法中,我们将开发一种外核酸酶消化阻滞方法,该方法使用下一代Solexa测序在未消除的DNA片段3'末端检测5-HMC;我们已经表明,在修饰的5-HMC的3'末端,化学修饰的5-HMC块外切核酸酶III消化。该SBIR应用中提出的新技术不仅具有广泛的价值作为商业研究试剂,而且也有望有效地发现和检测5-HMC作为各种人类疾病中的生物标志物。呢
公共卫生相关性:5-羟基甲基胞嘧啶(5-HMC)在某些哺乳动物组织和细胞的基因组DNA中出人意料地发现了新发现的基础修饰。提出的工作将开发有效的化学标记方法,以在基因组DNA中对5-HMC进行单基分辨率检测和测序。拟议工作的成功将使研究人员能够揭示5-HMC在生物学中的基本作用并发展潜在的疾病标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shuang Chang其他文献
Shuang Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别:
Investigators from Novices, a Transdisciplinary Research Education Program to Increase Diversity (INTREPID) in Aging Research
新手研究人员,一项旨在增加衰老研究多样性的跨学科研究教育计划 (INTREPID)
- 批准号:
10625709 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别: